期刊文献+

不同临床表型支气管哮喘儿童T淋巴细胞亚群改变 被引量:2

T-leukomonocyte subgroups in children with various clinical phenotypes of bronchial asthma
下载PDF
导出
摘要 目的探讨不同临床表型支气管哮喘儿童T淋巴细胞亚群改变情况,以期为儿童支气管哮喘的治疗提供理论依据。方法对23例婴儿短暂的喘息患儿、23例非特应性喘息患儿、41例特应性喘息/哮喘患儿外周血的T淋巴细胞亚群进行检测分析。结果特应性喘息/哮喘患儿CD4^+、CD4^+/CD8^+值高于婴儿短暂的喘息和非特应性喘息患儿,差异均有统计学意义(t值分别为2.843、2.873,均P<0.05);与FEV1/FVC和FEV1%呈明显的负相关(r值分别为-0.654、-0.676;-0.067、-0.675,均P<0.01),且与嗜酸性细胞计数和IgE呈正相关(r值分别为0.656、0.632;0.453、0.676,均P<0.01)。结论 T淋巴细胞亚群的改变可能是导致儿童发生特应性喘息/哮喘发病的因素,并且与特应性喘息/哮喘发病的严重程度密切相关。 Objective To explore the T-leukomonocyte subgroups in the children with various clinical phenotypes of bronchial asthma, so as to provide theoretical basis for treatment of children bronchial asthma. Methods Peripheral blood T-leukomonocyte subgroups were detected in 23 cases of infants with transient wheeze, 23 cases of nonatopic wheeze, and 41 cases of atopic wheeze/asthma, respectively. Results The contents of CD4 + and CD4 +/CD8 + were significantly higher in children with atopic wheeze/asthma than in those with transient wheeze and those with nonatopic wheeze, and the difference was statistically significant ( t value was 2. 843 and 2. 873, respectively, both P 〈0.05). They were negatively correlated with FEV1 / FVC and FEVI% (r value was - 0. 654, - 0. 676, - 0. 067 and - 0. 675, respectively, all P 〈 0.01 ). They were positively correlated with eosinophil count ( r value was 0. 656 and 0. 632, respectively, both P 〈 0.01 ) and IgE ( r value was 0. 453 and 0.676, respectively, both P 〈 0.01 ). Conclusion T-leukomonocyte subgroup change may be the factor leading children atopic wheeze/asthma, and it is closely related with the severity of atopic wheeze/asthma.
出处 《中国妇幼健康研究》 2014年第4期565-566,594,共3页 Chinese Journal of Woman and Child Health Research
关键词 支气管哮喘 儿童 表型 T淋巴细胞亚群 bronchial asthma children phenotypes T-leukomonocyte subgroup
  • 相关文献

参考文献8

  • 1Suglia S F, Enlow M B, Kullowatz A, et al. Maternal intimate partner violence and increased asthma incidence in children:Buffeting effects of supportive caregiving [ J ]. Arch Pediatr Adolesc Med, 2009,163 ( 3 ) :244-250.
  • 2杨锡强.小儿哮喘的免疫学发病机制及其对策[J].中国当代儿科杂志,2001,3(5):487-490. 被引量:95
  • 3Loebbermann J, Thornton H, Durant L, et al. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection [ J ].Mucosal Immunol, 2012,5(2) :161-172.
  • 4Wright A L. Epidemiology of asthma and recurrent wheeze in childhood [ J ]. Clin Rev Allergy Immunol, 2002,22 ( 1 ) : 33-44.
  • 5梁振宇,蔡绍曦,赵海金.哮喘的临床与炎症表型[J].中国呼吸与危重监护杂志,2010,9(5):546-548. 被引量:12
  • 6Brightling C E, Symon F A, Birring S S, et al. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes andbronchial submucosa isa feature of asthma and eosinophilic bronchitis [ J ]. J Allergy Clin Immunol,2002,110 ( 6 ) : 899-905.
  • 7Martinez F D. Development of wheezing disorders and asthma in preschool children[J]. Pediatrics ,2002,109 ( 3 ) :362-367.
  • 8Taussig L M, Wright A L, Holberg C J, et al. Tucson Children' s Respiratory Study: 1980 to present [ J]. J Allergy Clin lmmunol, 2003, 111 ( 1 ) ,661-675.

二级参考文献33

  • 1曹文利,孙永昌,姚婉贞.根据支气管哮喘患者痰嗜酸粒细胞计数调整糖皮质激素剂量的临床意义[J].中华结核和呼吸杂志,2007,30(5):334-338. 被引量:7
  • 2ML Fajt,SE Wenzel.Asthma phenotypes in adults and clinical implications.Expert Rev Resp Med,2009,3:607-625.
  • 3Haldar P,Pavord ID.Noneosinophilie asthma:a distinct clinical and pathologic phenotype.J Allergy Clin Immunol,2007,119:1043-1052.
  • 4Parameswaran K,Leigh R,Hargreave FE.Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma.J Allergy Clin Immunol,1999,104:502-503.
  • 5Green R,Brightling CE,McKenna S,et al.Asthma exacerbations and sputum eosinophil counts:a randomised controlled trial.Lancet,2002,360:1715-1721.
  • 6Jayaram L,Pizzichini MM,Cook RJ,et al.Determining asthma treatment by monitoring sputum cell counts:effect on exacerbations.Eur Respir J,2006,27:483-494.
  • 7Haldar P,Brightling CE,Hargadon B,et al.Mepolizumab and exacerbations of refractory eosinophilic asthma.N Engl J Med,2009,360:973-984.
  • 8Nair P,Pizziehini MM,Kjarsgaard M,et al.Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.N Engl J Med,2009,360:985 -993.
  • 9Leckie MJ,ten Brinke A,Khan J,et al.Effects of an interleukin-5blocking monoclonal antibody on eosinophils,airway hyperresponsiveness,and the late asthmatic response.Lancet,2000,356:2144-2148.
  • 10Flood-Page P,Swenson C,Faiferman I,et al.A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.Am J Respir Crit Care Med,2007,176:1062-1071.

共引文献105

同被引文献7

引证文献2

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部